14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZOM
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zomedica stock price ended at $0.141 on Thursday, after losing 0.283%.
(Updated on Jun 20, 2024)

Sell candidate since Jun 07, 2024 Loss -5.05% PDF

The Zomedica stock price fell by -0.283% on the last day (Thursday, 20th Jun 2024) from $0.141 to $0.141. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 1.63% from a day low at $0.141 to a day high of $0.143. The price has fallen in 7 of the last 10 days and is down by -9.9% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -832 thousand shares and in total, 2 million shares were bought and sold for approximately $332.33 thousand.

Given the current short-term trend, the stock is expected to rise 17.49% during the next 3 months and, with a 90% probability hold a price between $0.166 and $0.229 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZOM Signals & Forecast

There are few to no technical positive signals at the moment. The Zomedica stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.149 and $0.159. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 16, 2024, and so far it has fallen -23.49%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Zomedica stock

Zomedica finds support from accumulated volume at $0.140 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0023 between high and low, or 1.63%. For the last week the stock has had daily average volatility of 3.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ZOM) For The Upcoming Trading Day Of Friday 21st

For the upcoming trading day on Friday, 21st we expect Zomedica Pharmaceuticals Corp to open at $0.142, and during the day (based on 14 day Average True Range), to move between $0.133 and $0.149, which gives a possible trading interval of +/-$0.0079 (+/-5.63%) up or down from last closing price. If Zomedica Pharmaceuticals Corp takes out the full calculated possible swing range there will be an estimated 11.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.140 (0.71%) than the resistance at $0.146 (3.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Zomedica Pharmaceuticals Corp stock A Buy?

The Zomedica stock holds several negative signals and despite the positive trend, we believe Zomedica will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.105 Sell Candidate Unchanged

Predicted Opening Price for Zomedica Pharmaceuticals Corp of Friday, June 21, 2024

Fair opening price June 21, 2024 Current price
$0.142 ( 0.402%) $0.141

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZOM

Fibonacci Support & Resistance Levels

Level Price
R3 0.144 2.03%
R2 0.143 1.41%
R1 0.142 1.03%
Price 0.141
S1 0.141 -0.221%
S2 0.140 -0.606%
S3 0.139 -1.23%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.169 20.00%
R2 0.162 14.89%
R1 0.146 3.62%
Price 0.141
S1 0.140 -0.709%
S2 0.136 -3.48%
S3 0.124 -12.27%

FAQ

What is the symbol for Zomedica Stock and on which exchange is it traded?
The symbol for Zomedica is ZOM and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Zomedica Stock?
The Zomedica stock holds several negative signals and despite the positive trend, we believe Zomedica will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Zomedica Stock?
Zomedica Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zomedica Stock.

What's the current price of Zomedica Stock?
As of the end of day on the Jun 20, 2024, the price of an Zomedica (ZOM) share was $0.141.

What is the 52-week high and low for Zomedica Stock?
The 52-week high for Zomedica Stock is $0.245 and the 52-week low is $0.120.

What is the market capitalization of Zomedica Stock?
As of the Jun 20, 2024, the market capitalization of Zomedica is 138.173M.

When is the next earnings date for Zomedica?
The upcoming earnings date for Zomedica is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Zomedica Pharmaceuticals Corp

Zomedica Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and ... ZOM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT